Michaela Winkelmann
Translator — German
Stuttgart
Articles translated into German by Michaela Winkelmann
- HDBuzz needs your help
- Hats off to brain donors on Brain Donation Awareness Day
- 14 changes for a healthier brain
- Buckle in: Gene therapy AMT-130 appears to slow down signs of Huntington’s disease in Phase I/II clinical trial
- Two birds, one stone: HTT-lowering drugs also target CAG expansions
- Cry your eyes out: detecting huntingtin in tears
- The director’s cut: how CAG repeats change the editing of genetic messages
- Oz Buzz Video: Day 1
- Tipping the balance; new insights into HD genetic modifiers
- Huntington’s disease therapeutics conference 2023 - Day 3
- Huntington’s disease therapeutics conference 2023 - Day 2
- Huntington’s disease therapeutics conference 2023 - Day 1
- PROOF-HD study of pridopidine ends with negative result
- Astrocytes: The new star in HD research?
- Hunting for balance: how the huntingtin protein compensates in HD
- Sad news from Novartis: dosing suspended in VIBRANT-HD trial of branaplam
- Updates from uniQure about their gene therapy for Huntington's disease
- Vaccines and HD
- A faulty filter? Blood vessel changes in Huntington's disease
- EuroBuzz 2014 Video, day one
- Artificial intelligence to save the day? How clever computers are helping us understand Huntington’s disease.
- A new roadmap to track Huntington’s disease progression
- Shining a spotlight on huntingtin: a tool to measure huntingtin-lowering in real time
- BAC to basics: a more accurate mouse model for Huntington's disease
- What does COVID-19 mean for Huntington’s disease families and HD research?
- Huntington’s disease therapeutics conference 2022 - Day 2
- Huntington’s disease therapeutics conference 2022 - Day 3
- Important drug targets yielded by new genetic study of HD
- Through a Broader Lens: Looking at Non-Motor Symptoms in HD
- Treasure your exceptions - using outliers to understand Huntington's disease onset and progression
- Ultra-rare mutations highlight the importance of the HD gene in brain development
- Huntington's Disease Therapeutics Conference 2016 - day 3
- Huntington's Disease Therapeutics Conference 2016 - day 2
- Early exposure to the HD protein may cause life-long symptoms
- A powerful message: does a toxic RNA message molecule cause harm in Huntington's disease?
- Electron beam snaps best images yet of Huntington's disease protein
- Looking Past the Spin: Results from a Clinical Trial of Cysteamine
- Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms
- Taking new targets to the bank: the DNA repair protein ‘ATM’ is overactive in Huntington's disease
- Measuring harmful huntingtin protein in the brain’s bath water
- 2015 Huntington's Disease Therapeutics Conference: Day 3
- Buzzilia Video: Day 2
- 2015 Huntington's Disease Therapeutics Conference: Day 2
- 2015 Huntington's Disease Therapeutics Conference: Day 1
- Unlocking the Potential of Antibodies as a Therapy for Huntington’s Disease
- Drug Improves Huntington’s Symptoms in Mice – and Their Offspring
- mTORC1 tips the scales in Huntington’s disease mice
- Can this synthetic oil help feed the brain in Huntington's disease?
- Positive results announced for re-worked tetrabenazine drug in Huntington's disease
- EuroBuzz 2014: day one
- Turning skin cells into brain cells: a Huntington's disease research breakthrough?
- Melatonin alterations in Huntington's disease help explain trouble with sleep
- Should we worry about a huntingtin invasion?
- Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
- Largest creatine clinical trial for Huntington's disease halted after 'futility' analysis
- EuroBuzz 2014: day two
- EuroBuzz 2014: day three
- A starring role for astrocytes in Huntington's disease?
- The brain in Huntington's disease: greater than the sum of its parts?
- Raptor announces results of cysteamine trial for Huntington's disease
- NUB1: enhancing clearance to decrease mutant huntingtin
- 2CARE study of coenzyme Q for Huntington's disease ends in disappointment
- HD mice provide a useful failure
- Buzzilia Video: Day 1
- Prana announces results of Reach2HD trial of PBT2 for Huntington's disease
- Sleep, cilia and HD
- Huntington's Disease Therapeutics Conference 2014: day 2
- Huntington's Disease Therapeutics Conference 2014: day 3
- Huntington's Disease Therapeutics Conference 2014: day 1
- 2012 Therapeutics Conference: a retrospective
- Video feature: Huntington's disease research... in space!
- Does high-dose creatine "slow the onset" of Huntington's Disease?
- Joint HDBuzz Prizewinner: Yeast studies suggest a new way to protect cells from 'oxidative damage'
- Interview: Alice and Nancy Wexler
- Is a new technique set to revolutionize Huntington's disease genetic testing?
- Can sad mice help treat Huntington's disease?
- Simple rules for a good night's sleep in Huntington's disease
- Joint HDBuzz Prizewinner: Pennies for your neurons — copper’s bad influence on Huntington’s disease
- Could a 'brain shuttle' get Huntington's disease drugs to where they're needed?
- HD Therapeutics Conference 2013 Updates: Day 3
- Coming soon from the 2013 Huntington's Disease World Congress: Buzzilia!
- 'Buzzilia' from the Huntington's Disease World Congress: day 2
- Is a new Huntington’s Disease drug study on the right Trk?
- DNA shutdown proteins in Huntington's disease: More than meets the eye
- Do dairy foods accelerate Huntington's disease?
- More evidence points to Huntington's disease exercise benefit
- New study sheds light on regional degeneration in HD
- Could a new "jaw-dropping" breakthrough help treat Huntington's Disease?
- Does a 'rusty hinge' cause Huntington's disease?
- What the 'big neurodegeneration breakthrough' means for Huntington's disease
- Could muscle problems help explain movements in Huntington’s Disease patients?
- 'Buzzilia' from the Huntington's Disease World Congress: day 1
- How long is too long? Rethinking the Huntington’s disease ‘gray area’
- 'Buzzilia' from the Huntington's Disease World Congress: day 3
- The sweet lowdown: Huntington's disease brains use sugar differently
- The 2013 HDBuzz Prize for Young Science Writers
- 'Buzzilia' from the Huntington's Disease World Congress: day 4
- The 'N17' region of huntingtin protein: an address label in Huntington's disease?
- Gone fishing: protein network screen identifies new therapeutic targets in Huntington's disease
- Proposed Huntington's disease 'biomarker' is not useful, new study suggests
- No surprises in published results from HART study of Huntexil for Huntington's disease
- Lost in translation? New insights into the making of the Huntington's disease protein
- A DNA repair protein modifies the stability of long CAG tracts in the Huntington's disease gene
- Gene silencing drug safe in ALS patients... bring on Huntington's disease trials
- Start here!
- Major Roche-Isis deal boosts Huntington's disease gene silencing
- Landmark study puts Huntington's disease trials on TRACK
- Prana Biotech publishes Huntington's disease animal model data for PBT2
- The University of New Orleans has NOT discovered a cure for Huntington's disease
- Prominent Huntington's disease researcher "fabricated data" in grant applications
- Of mice and men: using animal models to study Huntington's disease
- Illuminating findings in blood cells from Huntington's disease patients
- HDBuzz Prize winner 2012: Deep brain stimulation for HD
- HDBuzz Prize runner-up 2012: Fruit flies, faulty connections and Huntington's disease
- Giving Huntington's disease the finger? Two teams report success for zinc-finger drugs in cells and mice
- EuroBuzz News: Day 2
- EuroBuzz News: Day 3
- Does the HD mutation affect children's growth?
- ASO gene silencing reaches further, lasts longer
- The HDBuzz Prize for young science writers
- Exercise increases cellular recycling
- Making babies: having a family, the HD way
- Double success for huntingtin RNAi gene silencing
- New analysis suggests 'small' CAG length doesn't matter after all
- Special 'brain fat' injection helps HD mice
- HDYO! Huntington's Disease Youth Organization goes live
- CHDI Report: Day 1
- CHDI Report: Day 2
- Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis
- Prana Biotech's new trial of PBT2 in Huntington's disease: the lowdown
- Could mesenchymal stem cells deliver gene silencing drugs?
- Therapeutics conference videos now online
- Coming soon from the HD World Congress: Oz Buzz!
- Dimebon fails in late-stage human HD clinical trial
- Huntexil hits the headlines again
- Chinese Huntington’s Disease Network launched
- Bone marrow transplantation in Huntington's Disease
- New experiments clarify the role of SIRT1 in HD - or do they?